Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids.

Yongbin Li,Jing Xu,Fang Wang,Bin Wang,Liqun Liu,Wanli Hou,Hong Fan,Yeqing Tong,Juan Zhang,Zuxun Lu
DOI: https://doi.org/10.1377/hlthaff.2010.0965
2012-01-01
Health Affairs
Abstract:In appropriate prescribing is a global problem. It is especially salient in China, where drug sales constitute a major portion of health care providers' incomes, price distortions are rampant, and oversight is lax. However, few data exist on the prevalence of inappropriate prescribing in China. This study, the first of its kind in China, examined 230,800 prescriptions written between 2007 and 2009 by 784 community health institutions in 28 cities across China. The data show substantial overprescribing, including twice as many prescriptions for antibiotics as recommended by the World Health Organization and rates of injection that are three times higher than in similar countries. These findings point to the need to integrate rational prescribing into China's ongoing health care reform.
What problem does this paper attempt to address?